Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check24 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check31 days agoChange DetectedThe study of KPT-8602 in participants with relapsed/refractory cancer indications has been completely removed from the page.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.